Serotonergic agents and alcoholism treatment: rebirth of the subtype concept--an hypothesis.
Johnson
B A
BA
Department of Psychiatry, University of Texas Health Science Center at San Antonio, USA. bjohnson@uthscsa.edu
D000437:Alcoholism / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics / Q000502:physiology; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D012701:Serotonin / Q000502:physiology; D018490:Serotonin Agents / Q000627:therapeutic use*; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D012701:Serotonin; D018490:Serotonin Agents; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; C493230:SLC6A4 protein, human